Transdermal technology specialist Futura Medicalis has made an – at least to say – interesting step in Saudi Arabia, country known for its conservative clergy and government, as it has launched a condom there through its distribution partner in the Middle East and North Africa (MENA), Kabey Pharmaceuticals.
Futura’s erectogenic condom called CSD500 has been launched under the name Futura Max Manex Super. Kabey expects to move on with the condom across MENA during 2017.
On Thursday, it was said in the press release that, in addition to raising further medical awareness of the product with urologists, Kabey will now implement a direct retail marketing campaign. Also, the marketing plans do not include online sales as, in the MENA region, this is not a popular route to market for such products.
James Barder, Futura’s Chief Executive, commented: “We are delighted that our novel erectogenic condom, CSD500, has now been launched in Saudi Arabia by our commercial partner in the Middle East and North Africa, Kabey Pharmaceuticals. The product launch follows positive feedback from urologists after their trial use of CSD500.
“Kabey is well-established with a strong presence in the MENA region. It will now implement a direct retail marketing campaign which we are confident will be successful for CSD500. We look forward to updating the market regarding further launches of CSD500 within MENA during 2017.”